Search

everythinglearnresearchcommunity

for

Search:↓

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Low-level light therapy is used in cosmetics and dermatology to repair skin, reduce inflammation, and treat various skin conditions.